Every report we publish — searchable by vendor, compound, grade, lab, or date. Verdict and grade are always public. Exact numbers are Data+ and above.
Want a compound on the bench? Tell us — leave an email and we’ll notify you when it’s tested.
Peptide · Sep 2025
n=1 vial
Anonymized vendor
Tirzepatide underdosed by 5.2%. COA does not match independent analysis.
SARM · Sep 2025
n=1 vial
Anonymized vendor
Semaglutide partially meets claim. Dose variance of 16.9% exceeds ±5% threshold.
Hormone · Mar 2025
n=1 vial
Anonymized vendor
Sermorelin partially meets claim. Dose variance of 10% exceeds ±5% threshold.
Nootropic · Feb 2025
n=1 vial
Anonymized vendor
Semaglutide meets claim. Measured dose within 11% of label. Purity confirmed.
Hormone · Nov 2024
n=1 vial
Anonymized vendor
Sermorelin largely meets claim. Minor variance (14%) within accepted tolerance.
Hormone · Oct 2024
n=1 vial
Anonymized vendor
Semaglutide partially meets claim. Dose variance of 8% exceeds ±5% threshold.
Selective Androgen · Aug 2024
n=1 vial
Anonymized vendor
PT-141 meets claim. Measured dose within 2.9% of label. Purity confirmed.
SARM · Jul 2024
n=1 vial
Anonymized vendor
Epithalon failed. Dose off by 10.9%. Identity or purity not confirmed.
SARM · Apr 2024
n=1 vial
Anonymized vendor
TB-500 meets claim. Measured dose within 9% of label. Purity confirmed.
Peptide · Feb 2024
n=1 vial
Anonymized vendor
TB-500 underdosed by 2%. COA does not match independent analysis.
Stay current
No membership required. We email findings when they're published — not updates, not promotions, just reports.
Powered by MailerLite. No spam. Unsubscribe anytime.